As cited by the research report titled ‘Global Primary Cell Culture Market Size study, by Product (Primary Cells, Reagents and Supplements, Media), Cell Type (Animal Cells, Human Cells), Separation Method (Explant Method, Enzymatic Degradation, Mechanical Separation, Others) Application (Tissue Culture & Tissue Engineering, Vaccine Production, Gene Therapy and Regenerative Medicine, Toxicity Testing and Drug Screening, Cancer Research, Model System, Virology, Prenatal Diagnosis, Stemm Cell Therapy, Others) and Regional Forecasts 2020-2027’, available with Market Study Report, global primary cell culture market was worth USD 3.05 billion in 2019 and is projected to grow with a CAGR of 11.06% over 2020-2027 to be appraised at USD 7.34 billion by the end of study duration.
 

Prevalence of cardiovascular diseases, growing number of cancer cases, rising expenditure on health care, and developments in genetic research are catalyzing the growth of global primary cell culture market.
 

According to WHO, around 71 million people were affected globally by chronic hepatitis C infection in 2020. As stated by the National Cancer Institute, number of cancer survivors in the U.S. was around 16.9 million in January 2019, which is expected to rise to 22.2 million by 2030.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3793434/
 

For the record, cell culture is a method of extracting cells from a plant or an animal source, and growing them under monitored conditions. This artificial environment with ideal pH, humidity, temperature, gases, and nutrition are cell culture growth help researchers to study microbiology and cell properties. Inflowing investments in research & development activities, and are rising popularity of stem cell therapy for treatment of chronic ailments will stimulate the market outlook.
 

However, lack of expertise, high capital required for investments, long time for approval of clinical trials and sluggish healthcare digitization are the factors impeding the growth of global primary cell market.
 

Based on product terrain, the industry is segmented into primary cells, media, and reagents & supplements. On the basis of cell type, the marketplace is divided into animal cells, and human cells. Speaking of separation method, worldwide primary cell culture business space is fragmented into explant method, mechanical separation, and enzymatic degradation including others.
 

Moving on to application ambit, the marketspace is classified into tissue engineering & tissue culture, regenerative medicine & gene therapy, vaccine production, toxicity testing & drug screening, prenatal diagnosis, model system, cancer research, virology, and stem cell therapy among others.
 

Geographically, Europe held significant market share in the recent past, owing to rising geriatric populace, affordable urgent care services, and well-established healthcare infrastructure.
 

Whereas, Asia Pacific market is likely to exhibit lucrative growth trends over the forecast duration, on account of rising incidences of injury, increasing medical expenditure, and advancing healthcare framework.
 

Leading players in global primary cell culture industry include MatTek Corporation, FUJIFILM Irvine Scientific Inc., ATCC (American Type Culture Collection), PromoCell GmbH, Danaher Corporation, Corning Incorporated, The Merck Group, Lonza Group AG, and Axol Bioscience Ltd.